华电博士英语课程Unit-4-----Abstract-2.pptVIP

Abstract 3 Owing to the economic growth in the pacific region, especially in the Mainland China, many multinational pharmaceutical companies have been expanding their business into these countries. For the past decade during the opening of the China market, Hong Kong has been regarded as the base for exploring this market. A questionnaire was designed to investigate the buying behavior of the medical practitioners. For all the respondents from both Hong Kong and the Mainland China, the most dominant influences were quality of the product and the reputation of the company. But differences emerged when the following factors were concerned: personal selling, credible scientific and clinical reports, price of the product, samples, sales bonus, seminars and conferences, advertising in medical journals, attractive promotional literature (促销文献), promotional materials and support, etc. Awareness of the differences can guide the multinational pharmaceutical companies (多国医药公司) to formulate cost-effective promotional strategies for the market in China. Abstract 4 When employers focus only on the direct, out-of-pocket costs of health care, they fail to consider the indirect costs of illness in the workplace from workers impaired functioning on the job and absenteeism. A case study is presented of the effects of clinical depression on direct and indirect health-related costs and a model is provided that employers can apply to a wide range of illness to analyze their investments in health care. The framework is applied to several workplace situations: employees depression, cigarette smoking breaks, and arthritis, to estimate the costs of lost productivity. A break-even analysis is also shown when employers investments in health interventions are likely to be justified. Since health service research is, in many respects, still in early stages, areas for further research are recommended at the end of this paper so that more efforts may be exerted. Abstract 5 This paper conducts s